20 01 Base Architecture Acute Myeloid Leukemia AML

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Ionut Alexandru Stefan
DOI: 10.5281/zenodo.18168091
Cited by: 0

Abstract

Acute myeloid leukemia (AML) presents a fundamental challenge in oncology: how do malignant cells maintainsurvival and proliferation within the tightly regulated bone marrow microenvironment while evading bothhomeostatic constraints and therapeutic intervention? Traditional approaches focus on genomic aberrationsand isolated cellular pathways, yet AML’s clinical heterogeneity and frequent relapse suggest a more complexsystems-level architecture

Fields of Study & Subjects

Acute Myeloid Leukemia Research Retinoids in leukemia and cellular processes Protein Degradation and Inhibitors

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
7 January 2026
Language
EN